bit.bio
PrivateLast Round
Series C
Jan 9, 2026
Est. Valuation
$500M
Total Funding Raised
$228.92M
Company Overview
bit.bio is a biotechnology company that provides human cells for research, drug discovery and cell therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
bit.bio Comparables
Compare bit.bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axol Bioscience | 82% | |
| BrainXell | 81% | |
| Ncardia | 80% | |
bit.bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 9, 2026 | ||||
| Growth Equity | Dec 16, 2024 | ||||
| Series B | Nov 5, 2021 | ||||
| Series A | Jun 13, 2020 | ||||
| Seed | Mar 27, 2019 | ||||
Seed | Nov 1, 2017 |
bit.bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metaplanet Holdings | Series B |
| BlueYard Capital | Series A, Growth Equity |
| ARCH Venture Partners | Series A, Growth Equity, Series B |
| ARCH Venture Partners | Growth Equity, Series A |
| M&G Investments | Series C, Growth Equity |
| Foresite Capital | Series B, Series A |
| Puhua Capital | Series B, Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2025
Received Platinum status in the Green Impact Awards for the second consecutive year.
- Sep 9, 2025
Attended the 13th World Congress on Alternatives and Animal Use in the Life Sciences.
bit.bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about bit.bio's valuation, stock price, and market status.